REFERENCESArmstrong BK (1988) Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J Dermatol Surg Oncol 14:835-49 Begg CB, Hummer AJ, Mujumdar U et al. (2006) A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol 35:756-64 Berwick M, Orlow I, Hummer AJ et al. (2006) The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev 15:1520-5 Bishop DT, Demenais F, Goldstein AM et al. (2002) Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 94:894-903 Cust AE, Harlnad M, Makalic E et al. (2011) Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK. J Med Genet 48:266-72 Gandini S, Sera F, Cattaruzza MS et al. (2005) Metaanalysis of risk factors for cutaneous melanoma: II* Sun exposure. Eur J Cancer 41:45-60 Goldstein AM, Falk RT, Fraser MC et al. (1998) Sun-related risk factors for melanoma-prone families with CDKN2A mutations. J Natl Cancer Inst 90:709-11 Kricker A, Armstrong BK, Goumas C et al. (2007) Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 18:295-304 Nielsen K, Harbst K, Måsbäck A (2010) Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype. Melanoma Res 20:266-72 Orlow I, Begg CB, Cotignola J et al. (2007) CDKN2A germline mutations in individuals with cutaneous malignant melanoma.